Search | VHL Search Portal

1.

Coordinating Cardiology clinics randomized trial of interventions to improve outcomes (COORDINATE) - Diabetes: rationale and design.

Nelson, Adam J; Pagidipati, Neha J; Kelsey, Michelle D; Ardissino, Maddalena; Aroda, Vanita R; Cavender, Matthew A; Lopes, Renato D; Al-Khalidi, Hussein R; Braceras, Rogelio; Gaynor, Tanya; Kaltenbach, Lisa A; Kirk, Julienne K; Lingvay, Ildiko; Magwire, Melissa L; O'Brien, Emily C; Pak, Jonathan; Pop-Busui, Rodica; Richardson, Caroline R; Levya, Monica; Senyucel, Cagri; Webb, Laura; McGuire, Darren K; Green, Jennifer B; Granger, Christopher B.

Am Heart J ; 256: 2-12, 2023 02.

Article in English | MEDLINE | ID: mdl-36279931

2.

Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical Trial.

Pagidipati, Neha J; Nelson, Adam J; Kaltenbach, Lisa A; Leyva, Monica; McGuire, Darren K; Pop-Busui, Rodica; Cavender, Matthew A; Aroda, Vanita R; Magwire, Melissa L; Richardson, Caroline R; Lingvay, Ildiko; Kirk, Julienne K; Al-Khalidi, Hussein R; Webb, Laura; Gaynor, Tanya; Pak, Jonathan; Senyucel, Cagri; Lopes, Renato D; Green, Jennifer B; Granger, Christopher B.

JAMA ; 329(15): 1261-1270, 2023 04 18.

Article in English | MEDLINE | ID: mdl-36877177

3.

Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community.

Nelson, Adam J; Pagidipati, Neha J; Aroda, Vanita R; Cavender, Matthew A; Green, Jennifer B; Lopes, Renato D; Al-Khalidi, Hussein; Gaynor, Tanya; Kaltenbach, Lisa A; Kirk, Julienne K; Lingvay, Ildiko; Magwire, Melissa L; O'Brien, Emily C; Pak, Jonathan; Pop-Busui, Rodica; Richardson, Caroline R; Reed, Monica; Senyucel, Cagri; Webb, Laura; McGuire, Darren K; Granger, Christopher B.

Circulation ; 144(1): 74-84, 2021 07 06.

Article in English | MEDLINE | ID: mdl-34228476

4.

Inhibition of p38 MAP kinase in patients with ST-elevation myocardial infarction - findings from the LATITUDE-TIMI 60 trial.

Cavender, Matthew A; O'Donoghue, Michelle L; Abbate, Antonio; Aylward, Philip; Fox, Keith Aa; Glaser, Ruchira X; Park, Jeong-Gun; Lopez-Sendon, Jose; Steg, Ph Gabriele; Sabatine, Marc S; Morrow, David A.

Am Heart J ; 243: 147-157, 2022 01.

Article in English | MEDLINE | ID: mdl-34508693

5.

Role of Primary Care Clinicians in the Management of Patients With Type 2 Diabetes and Cardiorenal Diseases.

Kushner, Pamela R; Cavender, Matthew A; Mende, Christian W.

Clin Diabetes ; 40(4): 401-412, 2022.

Article in English | MEDLINE | ID: mdl-36381309

6.

SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.

Tuttle, Katherine R; Brosius, Frank C; Cavender, Matthew A; Fioretto, Paola; Fowler, Kevin J; Heerspink, Hiddo J L; Manley, Tom; McGuire, Darren K; Molitch, Mark E; Mottl, Amy K; Perreault, Leigh; Rosas, Sylvia E; Rossing, Peter; Sola, Laura; Vallon, Volker; Wanner, Christoph; Perkovic, Vlado.

Am J Kidney Dis ; 77(1): 94-109, 2021 01.

Article in English | MEDLINE | ID: mdl-33121838

7.

Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data.

Khunti, Kamlesh; Kosiborod, Mikhail; Kim, Dae Jung; Kohsaka, Shun; Lam, Carolyn S P; Goh, Su-Yen; Chiang, Chern-En; Shaw, Jonathan E; Cavender, Matthew A; Tangri, Navdeep; Franch-Nadal, Josep; Holl, Reinhard W; Jørgensen, Marit E; Norhammar, Anna; Eriksson, Johan G; Zaccardi, Francesco; Karasik, Avraham; Magliano, Dianna J; Thuresson, Marcus; Chen, Hungta; Wittbrodt, Eric; Bodegård, Johan; Surmont, Filip; Fenici, Peter.

Cardiovasc Diabetol ; 20(1): 159, 2021 07 31.

Article in English | MEDLINE | ID: mdl-34332558

8.

Association of sodium-glucose cotransporter-2 inhibitors with outcomes in type 2 diabetes with reduced and preserved left ventricular ejection fraction: Analysis from the CVD-REAL 2 study.

Lam, Carolyn S P; Karasik, Avraham; Melzer-Cohen, Cheli; Cavender, Matthew A; Kohsaka, Shun; Norhammar, Anna; Thuresson, Marcus; Chen, Hungta; Wittbrodt, Eric; Fenici, Peter; Kosiborod, Mikhail.

Diabetes Obes Metab ; 23(6): 1431-1435, 2021 06.

Article in English | MEDLINE | ID: mdl-33606906

9.

Emerging opportunities to harness real world data: An introduction to data sources, concepts, and applications.

O'Leary, Colin P; Cavender, Matthew A.

Diabetes Obes Metab ; 22 Suppl 3: 3-12, 2020 04.

Article in English | MEDLINE | ID: mdl-32250526

10.

Once-weekly semaglutide reduces the risk of cardiovascular events in people with type 2 diabetes and polyvascular disease: A post hoc analysis.

Kobo, Ofer; Cavender, Matthew A; Jensen, Thomas Jon; Kuhlman, Anja Birk; Rasmussen, Søren; Verma, Subodh.

Diabetes Obes Metab ; 26(3): 1129-1132, 2024 Mar.

Article in English | MEDLINE | ID: mdl-38082468

11.

Hypertension Treatment in Diabetes: Focus on Heart Failure Prevention.

Bensimhon, Hannah F; Cavender, Matthew A.

Heart Fail Clin ; 15(4): 551-563, 2019 Oct.

Article in English | MEDLINE | ID: mdl-31472890

12.

Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors.

Nauck, Michael A; Meier, Juris J; Cavender, Matthew A; Abd El Aziz, Mirna; Drucker, Daniel J.

Circulation ; 136(9): 849-870, 2017 Aug 29.

Article in English | MEDLINE | ID: mdl-28847797

13.

Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care).

Cavender, Matthew A; White, William B; Jarolim, Petr; Bakris, George L; Cushman, William C; Kupfer, Stuart; Gao, Qi; Mehta, Cyrus R; Zannad, Faiez; Cannon, Christopher P; Morrow, David A.

Circulation ; 135(20): 1911-1921, 2017 May 16.

Article in English | MEDLINE | ID: mdl-28246236

14.

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).

Kosiborod, Mikhail; Cavender, Matthew A; Fu, Alex Z; Wilding, John P; Khunti, Kamlesh; Holl, Reinhard W; Norhammar, Anna; Birkeland, Kåre I; Jørgensen, Marit Eika; Thuresson, Marcus; Arya, Niki; Bodegård, Johan; Hammar, Niklas; Fenici, Peter.

Circulation ; 136(3): 249-259, 2017 Jul 18.

Article in English | MEDLINE | ID: mdl-28522450

15.

Meta-analysis of transfemoral TAVR versus surgical aortic valve replacement.

Arora, Sameer; Vaidya, Satyanarayana R; Strassle, Paula D; Misenheimer, Jacob A; Rhodes, Jeremy A; Ramm, Cassandra J; Wheeler, Evan N; Caranasos, Thomas G; Cavender, Matthew A; Vavalle, John P.

Catheter Cardiovasc Interv ; 91(4): 806-812, 2018 03 01.

Article in English | MEDLINE | ID: mdl-29068166

16.

Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study.

Kosiborod, Mikhail; Birkeland, Kåre I; Cavender, Matthew A; Fu, Alex Z; Wilding, John P; Khunti, Kamlesh; Holl, Reinhard W; Norhammar, Anna; Jørgensen, Marit E; Wittbrodt, Eric T; Thuresson, Marcus; Bodegård, Johan; Hammar, Niklas; Fenici, Peter.

Diabetes Obes Metab ; 20(8): 1983-1987, 2018 08.

Article in English | MEDLINE | ID: mdl-29569378

17.

Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study.

Goh, Su-Yen; Kosiborod, Mikhail N; Lam, Carolyn S P; Cavender, Matthew A; Kohsaka, Shun; Norhammar, Anna; Birkeland, Kåre I; Holl, Reinhard W; Mauricio, Dídac; Tangri, Navdeep; Shaw, Jonathan E; Thuresson, Marcus; Fenici, Peter; Kim, Dae Jung.

Diabetes Obes Metab ; 25(8): 2402-2409, 2023 08.

Article in English | MEDLINE | ID: mdl-37055714

18.

Consistent Reduction in Periprocedural Myocardial Infarction With Cangrelor as Assessed by Multiple Definitions: Findings From CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition).

Cavender, Matthew A; Bhatt, Deepak L; Stone, Gregg W; White, Harvey D; Steg, Ph Gabriel; Gibson, C Michael; Hamm, Christian W; Price, Matthew J; Leonardi, Sergio; Prats, Jayne; Deliargyris, Efthymios N; Mahaffey, Kenneth W; Harrington, Robert A.

Circulation ; 134(10): 723-33, 2016 Sep 06.

Article in English | MEDLINE | ID: mdl-27482008

19.

Blood pressure lowering in the prevention of type 2 diabetes.

Cavender, Matthew A; Wirka, Robert C.

Lancet ; 398(10313): 1778-1779, 2021 11 13.

Article in English | MEDLINE | ID: mdl-34774133

20.

Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry.

Cavender, Matthew A; Steg, Ph Gabriel; Smith, Sidney C; Eagle, Kim; Ohman, E Magnus; Goto, Shinya; Kuder, Julia; Im, Kyungah; Wilson, Peter W F; Bhatt, Deepak L.

Circulation ; 132(10): 923-31, 2015 Sep 08.

Article in English | MEDLINE | ID: mdl-26152709

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export: